Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma

Journal of Clinical Investigation

Volumn 101, Issue 10, 1998, Pages 2151-2164

  Fan, Jianglin ^b   Ji, Zhong Sheng ^b   Huang, Yadong ^b   De Silva, Harshini ^b   Sanan, David ^a   Mahley, Robert W ^b,c   Innerarity, Thomas L ^b,c   Taylor, John M ^a,b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apo E; Lipoprotein receptors; Remnant lipoproteins; Transgenic rabbits

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RABBIT; RECEPTOR BINDING; TRANSGENIC ANIMAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032523950     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1599     Document Type: Article

References (72)

1. Mahley, R.W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:622-630.
2. Rall, S.C., Jr., K.H. Weisgraber, and R.W. Mahley. 1982. Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem. 257:4171-4178.
3. Paik, Y.-K., D.J. Chang, C.A. Reardon, G.E. Davies, R.W. Mahley, and J.M. Taylor. 1985. Nucleotide sequence and structure of the human apolipoprotein E gene. Proc. Natl. Acad. Sci. USA. 82:3445-3449.
4. Das, H.K., J. McPherson, G.A.P. Bruns, S.K. Karathanasis, and J.L. Breslow. 1985. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260:6240-6247.
5. Kraft, H.G., H.J. Menzel, F. Hoppichler, W. Vogel, and G. Utermann. 1989. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J. Clin. Invest. 83:137-142.
6. Elshourbagy, N.A., W.S. Liao, R.W. Mahley, and J.M. Taylor. 1985. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA. 82:203-207.
7. Linton, M.F., R. Gish, S.T. Hubl, E. Bütler, C. Esquivel, W.I. Bry, J.K. Boyles, M.R. Wardell, and S.G. Young. 1991. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88:270-281.
8. Ji, Z.-S., S. Fazio, Y.-L. Lee, and R.W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269:2764-2772.
9. Mahley, R.W., and S.C. Rall, Jr. 1995. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic and Molecular Bases of Inherited Disease. 7th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill, New York. 1953-1980.
10. Mahley, R.W., and T.L. Innerarity. 1983. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta. 737:197-222.
11. Mahley, R.W. 1996. Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease. Isr. J. Med. Sci. 32:414-429.
12. Dong, L.-M., and K.H. Weisgraber. 1996. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271:19053-19057.
13. Davignon, J., R.E. Gregg, and C.F. Sing. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1-21.
14. Strittmatter, W.J., K.H. Weisgraber, D.Y. Huang, L.-M. Dong, G.S. Salvesen, M. Pericak-Vance, D. Schmechel, A.M. Saunders, D. Goldgaber, and A.D. Roses. 1993. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:8098-8102.
15. Nathan, B.P., S. Bellosta, D.A. Sanan, K.H. Weisgraber, R.W. Mahley, and R.E. Pitas. 1994. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:850-852.
16. Havel, R.J., T. Kita, L. Kotite, J.P. Kane, R.L. Hamilton, J.L. Goldstein, and M.S. Brown. 1982. Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia. Arteriosclerosis. 2:467-474.
17. Lusis, A.J., B.A. Taylor, D. Quon, S. Zollman, and R.C. LeBoeuf. 1987. Genetic factors controlling structure and expression of apolipoproteins B and E in mice. J. Biol. Chem. 262:7594-7604.
18. Mahley, R.W., K.H. Weisgraber, M.M. Hussain, B. Greenman, M. Fisher, T. Vogel, and M. Gorecki. 1989. Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J. Clin. Invest. 83: 2125-2130.
19. Yamada, N., H. Shimano, H. Mokuno, S. Ishibashi, T. Gotohda, M. Kawakami, Y. Watanabe, Y. Akanuma, T. Murase, and F. Takaku. 1989. Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA. 86:665-669.
20. Overturf, M.L., and D.S. Loose-Mitchell. 1992. In vivo model systems: the choice of the experimental animal model for analysis of lipoproteins and atherosclerosis. Curr. Opin. Lipidol. 3:179-185.
21. Warren, R.J., D.L. Ebert, A. Mitchell, and P.J. Barter. 1991. Rabbit hepatic lipase cDNA sequence: low activity is associated with low messenger RNA levels. J. Lipid Res. 32:1333-1339.
22. Kinnunen, P.K.J. 1984. Hepatic endothelial lipase. Isolation, some characteristics, and physiological role. In Lipases. B. Borgström and H.L. Brockman, editors. Elsevier Science Publishers, Amsterdam. 307-328.
23. Sanan, D.A., J. Fan, A. Bensadoun, and J.M. Taylor. 1997. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J. Lipid Res. 38:1002-1013.
24. Tall, A.R. 1986. Plasma lipid transfer proteins. J. Lipid Res. 27:361-367.
25. Ji, Z.-S., S.J. Lauer, S. Fazio, A. Bensadoun, J.M. Taylor, and R.W. Mahley. 1994. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J. Biol. Chem. 269:13429-13436.
26. Thuren, T., R.W. Wilcox, P. Sisson, and M. Waite. 1991. Hepatic lipase hydrolysis of lipid monolayers. Regulation by apolipoproteins. J. Biol. Chem. 266:4853-4861.
27. Ji, Z.-S., H.L. Dichek, R.D. Miranda, and R.W. Mahles. Heparan sulfate proteoglycans participate in hepatic lipase-and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J. Biol. Chem. 272:31285-31292.
28. Tall, A.R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34:1255-1274.
29. Yamanaka, S., M.E. Balestra, L.D. Ferrell, J. Fan, K.S. Arnold, S. Taylor, J.M. Taylor, and T.L. Innerarity. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA. 92:8483-8487.
30. Poorman, J.A., R.A. Buck, S.A. Smith, M.L. Overturf, and D.S. Loose-Mitchell. 1993. Bile acid excretion and cholesterol 7α-hydroxylase expression in hypercholesterolemia-resistant rabbits. J. Lipid Res. 34:1675-1685.
31. Simonet, W.S., N. Bucay, S.J. Lauer, and J.M. Taylor. 1993. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268: 8221-8229.
32. Fan, J., J. Wang, A. Bensadoun, S.J. Lauer, Q. Dang, R.W. Mahley, and J.M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91:8724-8728.
33. Taylor, J.M., and J. Fan. 1997. Transgenic rabbit models for the study of atherosclerosis. Front. Biosci. 2:298-308.
34. Wahl, G.M., J.L. Meinkoth, and A.R. Kimmel. 1987. Northern and Southern blots. Methods Enzymol. 152:572-581.
35. Weisgraber, K.H. 1994. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45:249-302.
36. Lee, B.-R., J.M. Miller, C.-Y. Yang, L. Ramdas, M. Yang, J.D. Morrisett, and M.P. Mims. 1991. Amino acid sequence of rabbit apolipoprotein E. J. Lipid Res. 32:165-171.
37. de Silva, H.V., S.J. Lauer, J. Wang, W.S. Simonet, K.H. Weisgraber, R.W. Mahley, and J.M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269:2324-2335.
38. Innerarity, T.L., R.E. Pitas, and R.W. Mahley. 1979. Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J. Biol. Chem. 254:4186-4190.
39. Arnold, K.S., T.L. Innerarity, R.E. Pitas, and R.W. Mahley. 1992. Lipoprotein-receptor interactions. In Lipoprotein Analysis. A Practical Approach. C.A. Converse and E.R. Skinner, editors. Oxford University Press, Oxford. 145-168.
40. Mahley, R.W., and K.H. Weisgraber. 1974. Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs. Circ. Res. 35:713-721.
41. Hussain, M.M., R.W. Mahley, J.K. Boyles, P.A. Lindquist, W.J. Brecht, and T.L. Innerarity. 1989. Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species. J. Biol. Chem. 264:17931-17938.
42. Huettinger, M., W.J. Schneider, Y.K. Ho, J.L. Goldstein, and M.S. Brown. 1984. Use of monoclonal anti-receptor antibodies to probe the expression of the low density lipoprotein receptor in tissues of normal and Watanabe Heritable Hyperlipidemic rabbits. J. Clin. Invest. 74:1017-1026.
43. Hussain, M.M., T.L. Innerarity, W.J. Brecht, and R.W. Mahley. 1995. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway. J. Biol. Chem. 270:8578-8587.
44. Borensztajn, J., G.S. Getz, and T.J. Kotlar. 1988. Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids. J. Lipid Res. 29:1087-1096.
45. McKeone, B.J., J.R. Patsch, and H.J. Pownall. 1993. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J. Clin. Invest. 91:1926-1933.
46. Connelly, P.W., G.F. Maguire, C. Vezina, R.A. Hegele, and A. Kuksis. 1994. Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content. J. Biol. Chem. 269:20554-20560.
47. Iverius, P.-H., U. Lindahl, T. Egelrud, and T. Olivecrona. 1972. Effects of heparin on lipoprotein lipase from bovine milk. J. Biol. Chem. 247:6610-6616.
48. Innerarity, T.L., R.E. Pitas, and R.W. Mahley. 1980. Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus. Biochemistry. 19:4359-4365.
49. Hennessy, L.K., S.T. Kunitake, M. Jarvis, R.L. Hamilton, G. Endeman, A. Protter, and J.P. Kane. 1997. Isolation of subpopulations of high density lipoproteins: three particle species containing apo E and two species devoid of apo E that have affinity for heparin. J. Lipid Res. 38:1859-1868.
50. Hussain, M.M., R.W. Mahley, J.K. Boyles, M. Fainaru, W.J. Brecht, and P.A. Lindquist. 1989. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J. Biol. Chem. 264:9571-9582.
51. 2-macroglobulin receptor. J. Biol. Chem. 266:13936-13940.
52. Ji, Z.-S., W.J. Brecht, R.D. Miranda, M.M. Hussain, T.L. Innerarity, and R.W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268:10160-10167.
53. Choi, S.Y., L.G. Fong, M.J. Kirven, and A.D. Cooper. 1991. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J. Clin. Invest. 88:1173-1181.
54. Koo, C., M.E. Wernette-Hammond, Z. Garcia, M.J. Malloy, R. Uauy, C. East, D.W. Bilheimer, R.W. Mahley, and T.L. Innerarity. 1988. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors. J. Clin. Invest. 81: 1332-1340.
55. Herz, J., S.-Q. Qiu, A. Oesterle, H.V. de Silva, S. Shafi, and R.J. Havel. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92:4611-4615.
56. Kowal, R.C., J. Herz, J.L. Goldstein, V. Esser, and M.S. Brown. 1989. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA. 86:5810-5814.
57. Ji, Z.-S., D.A. Sanan, and R.W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36:583-592.
58. Rensen, P.C.N., N. Herijgers, M.H. Netscher, S.C.J. Meskers, M. van Eck, and T.J.C. van Berkel. 1997. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J. Lipid Res. 38:1070-1084.
59. Olivecrona, T., and G. Bengtsson-Olivecrona. 1990. Lipoprotein lipase and hepatic lipase. Curr. Opin. Lipidol. 1:222-230.
60. Eckel, R.H. 1989. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320:1060-1068.
61. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88:8342-8346.
62. Zambon, A., I. Schmidt, U. Beisiegel, and J.D. Brunzell. 1996. Dimeric lipoprotein lipase is hound to triglyceride-rich plasma lipoproteins. J. Lipid Res. 37:2394-2404.
63. Williams, K.J., G.M. Fless, K.A. Petrie, M.L. Snyder, R.W. Brocia, and T.L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267:13284-13292.
64. van Barlingen, H.H.J.J., H. de Jong, D.W. Erkelens, and T.W.A. de Bruin. 1996. Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C. J. Lipid Res. 37:754-763.
65. Rensen, P.C.N., and T.J.C. van Berkel. 1996. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J. Biol. Chem. 271:14791-14799.
66. Grundy, S.M. 1991. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease. Arterioscler. Thromb. 11: 1619-1635.
67. Woollett, L.A., Y. Osono, J. Herz, and J.M. Dietschy. 1995. Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse. Proc. Natl. Acad. Sci. USA. 92:12500-12504.
68. Mahley, R.W., and T.L. Innerarity. 1978. Properties of lipoproteins responsible for high affinity binding to cell surface receptors of fibroblasts and smooth muscle cells. Adv. Exp. Med. Biol. 109:99-127.
69. Huang, Y., S.W. Schwendner, S.C. Rall, Jr., D.A. Sanan, and R.W. Mahley. 1997. Apolipoprotein E2 transgenic rabbits: modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis. J. Biol. Chem. 272:22685-22694.
70. Shimano, H., N. Yamada, M. Katsuki, M. Shimada, T. Gotoda, K. Harada, T. Murase, C. Fukazawa, F. Takaku, and Y. Yazaki. 1992. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 89:1750-1754.
71. Greeve, J., I. Altkemper, J.-H. Dieterich, H. Greten, and E. Windler. 1993. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apo B-containing plasma lipoproteins. J. Lipid Res. 34:1367-1383.
72. Davidson, N.O. 1994. RNA editing of the apolipoprotein B gene. A mechanism to regulate the atherogenic potential of intestinal lipoproteins? Trends Cardiovasc. Med. 4:231-235.